Showing 561-570 of 8196 results for "".
SDPA: Medical Director Dr. Hilary Baldwin on Conference Planning Process
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-medical-director-dr-hilary-baldwin-conference-planning-process/29507/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with conference medical director Hilary Baldwin, MD. Dr. Baldwin shares insights on the process of planning SDPA.DermWire TV Extra: Dr. Bunick on BPO Study
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-dr-bunick-bpo-study/29165/Practical Dermatology Editorial Board member Christopher Bunick, MD, FAAD, discusses the new Journal of Investigative Dermatology article he co-authored, "Evaluation of Benzene Presence and Formulation in Benzoyl Peroxide Drug Products."What are Dermatologists’ Obstacles to Buy and Bill?
https://practicaldermatology.com/conferences/maui-derm-2024/what-are-dermatologists-obstacles-to-buy-and-bill/20241/Challenges with fee schedules have prompted many dermatologists to consider the buy and bill model. In a conversation between Practical Dermatology’s Chief Medical Editor Neal Bhatia, MD and Mark Kaufmann, MD, associate clinical professor at Mount Sinai, the doctors discuss some of the opportunitiesDermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatologyBurnout; Qwo Campaign; Differin, Cetaphil Programs; DermTech Data: DermWireTV
https://practicaldermatology.com/topics/skin-cancer-photoprotection/burnout-qwo-campaign-differin-cetaphil-programs-dermtech-data-dermwiretv/20063/The Dr. Lorna Breen Health Care Provider Protection Act is headed to the president, as the latest Medscape Physician Burnout and Depression Report shows more than half of physicians experiencing burnout say it has a strong or severe impact on their life. Differin marks Retinoid Awareness Week. CetapDermWireTV Extra: Lubriderm Launches Skin Scholarship with the NHHF
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-extra-lubriderm-launches-skin-scholarship-with-the-nhhf/20060/Suzanne Goldstein, Senior Director of Marketing for Lubriderm, explains the Skin Scholarship sponsored by Lubriderm and created in partnership with the National Hispanic Health Foundation (NHHF). This scholarship program aims to increase representation and accessibility within the field.Exploring High-Dose Neurotoxin Injections
https://practicaldermatology.com/conferences/maui-derm-2022/exploring-high-dose-neurotoxin-injections/20055/Michael H. Gold, MD shares his thoughts on the potential benefits of high-dose neurotoxin injections for some patients. He discusses his experience and the kind of results he's been able to achieve.Winning Combinations in Cosmetic Dermatology
https://practicaldermatology.com/conferences/maui-derm-2022/winning-combinations-in-cosmetic-dermatology/20280/When it comes to ensuring the best results possible for aesthetic treatments, Suneel Chilukuri, MD says combinations are key. He discusses his approach for patients using neurotoxins, fillers, and devices.DermWireTV: A Review of 2021
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-a-review-of-2021/20039/This special edition of DermWireTV reviews some of the trends that shaped the dermatology space in 2021. The availability of vaccinations against SARS-CoV-2 brought concerns about potential cutaneous reactions. Physicians in 2021 saw a decrease in salary, as the physician employment trend continuedDilution Evolution
https://practicaldermatology.com/conferences/asds-2021/dilution-evolution/20025/Offering a global perspective on aesthetics, Hassan Galadari, MD discusses the use of hyperdilute calcium hydroxyapatite in the lower face, neck, and decolette. He describes the potential for this treatment to come to the US.